IRVINE, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) — CANNABINOL (CBN) Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development via NEWMEDIAWIRE — Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it intends to expand the scope of its sponsored research in Nigeria to include neurological conditions, including Post-Traumatic Stress Disorder (PTSD).
Home Cannabis / Wiet Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include...